Find News

Filter articles

Applied Filters

Showing 21 to 30 of 730 results

Fed Circ backs ITC on E. coli patent dispute

US07-08-2019Sarah Morgan

The US Court of Appeals for the Federal Circuit yesterday, August 6, affirmed a US International Trade Commission decision to uphold a patent related to E. coli bacteria.

Exact Sciences and Genomic Health in $2.8bn merger

US31-07-2019Rory O'Neill

Exact Sciences will acquire Genomic Health in a merger deal worth $2.8 billion.

Federal Circuit dismisses Amgen’s Neulasta appeal


California-based Amgen is barred from succeeding on its patent infringement claim against Coherus Biosciences, according to the US Court of Appeals for the Federal Circuit.

Sigma-Aldrich submits CRISPR petition at USPTO

US23-07-2019Sarah Morgan

Merck KGaA-owned Sigma-Aldrich has petitioned the US Patent and Trademark Office to open an interference proceeding between its own pending CRISPR-Cas9 patents and patents awarded to the University of California, Berkeley.

EU invests €35m into AI cancer diagnostics

EU10-07-2019Sarah Morgan

The European Commission has pledged €35 million to promote the development of analysis of health images for cancer diagnostics, based on artificial intelligence.

Cancer Research UK partners with VC firm in $25m deal


Charity Cancer Research UK has united with SV Health Investors, a venture capital and growth equity firm, to develop new cancer medicines for patients.

Carpmaels & Ransford name two new partners


Carpmaels & Ransford has appointed two life sciences attorneys as partners, effective yesterday, July 1.

Jury awards $2.4m in broccoli trade secrets suit


A Kentucky jury has awarded a seed company $2.4 million, after finding that an ex-employee had misappropriated trade secrets related to work on broccoli seeds and sprouts.

MoFo hires FDA-focused partner


Morrison & Foerster has strengthened its life sciences group with the addition of Bethany Hills as a partner in New York.

USPTO revives fight over CRISPR patents


The US Patent and Trademark Office has revived the dispute between the Broad Institute of MIT and Harvard and the University of California, Berkeley over which first invented the CRISPR gene-editing technology.

Showing 21 to 30 of 730 results